Skip to main content

Acute Compartment Syndrome

0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Nonin
NoninMN - Plymouth
2 programs
Near infrared spectroscopyN/A1 trial
ShavingN/A1 trial
Active Trials
NCT01171638Unknown120Est. Dec 2012
NCT01284023Completed44Est. Aug 2012
MY01
MY01QC - Montréal
1 program
MY01 - Continuous Compartmental Pressure MonitorN/A1 trial
Active Trials
NCT04016103Completed50Est. Jun 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MY01MY01 - Continuous Compartmental Pressure Monitor
NoninNear infrared spectroscopy
NoninShaving

Clinical Trials (3)

Total enrollment: 214 patients across 3 trials

NCT04016103MY01MY01 - Continuous Compartmental Pressure Monitor

MY01 - An Aid for Diagnosing Acute Compartment Syndrome in Real Time

Start: Jul 2020Est. completion: Jun 202350 patients
N/ACompleted
NCT01171638NoninNear infrared spectroscopy

The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome

Start: Sep 2011Est. completion: Dec 2012120 patients
N/AUnknown

Use of Near Infrared Spectroscopy to Detect Muscle Perfusion in the Lower Extremity of Uninjured Subjects

Start: Jan 2011Est. completion: Aug 201244 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.